TITLE

Saxagliptin Tablets (Onglyza)

AUTHOR(S)
Elliott, William T.; Chan, James
PUB. DATE
September 2009
SOURCE
Internal Medicine Alert;9/29/2009, Vol. 31 Issue 18, p141
SOURCE TYPE
Periodical
DOC. TYPE
Product Review
ABSTRACT
The article evaluates the diabetes mellitus treatment drug Saxaglipitin, Dipeptidyl peptidase-4 (DPP-4) by Bristol-Myers Squibb Co.
ACCESSION #
44453976

 

Related Articles

  • New molecular entity.  // Formulary;Sep2009, Vol. 44 Issue 9, p261 

    The article evaluates the Onglyza Saxaglipitin drug from Bristol-Myers Squibb Co. and Astrazeneca for the treatment of type 2 diabetes mellitus.

  • New molecular entities.  // Formulary;Dec2007, Vol. 42 Issue 12, p661 

    The article evaluates the two therapeutic drugs the Raltegravir from Merck & Co., Inc., and the Ixabepilone from Bristol-Myers Squibb Co.

  • New Steroid Insert for DME. Shechtman, Diana L. // Review of Optometry;5/15/2009, Vol. 146 Issue 5, p98 

    The article evaluates several corticosteroids drugs for diabetic macular edema including Kenalog intravitreal steroid injection from Bristol-Myers Squibb Co., Retisert suture implant steroid from Bausch & Lomb Inc., and Iluvien injectable intravitreal steroid.

  • NEW PRODUCTS.  // Monthly Prescribing Reference;Mar2014, Vol. 30 Issue 3, pA5 

    The article evaluates the Duavee, conjugated estrogens and bazedoxifene tablets, from Pfizer Inc. and the Farxiga, dapagliflozin film-coated tablets, from Bristol-Myers Squibb Co. and AstraZeneca PLC.

  • NEW PRODUCTS.  // Monthly Prescribing Reference;Sep2015, Vol. 31 Issue 9, pA12 

    The article offers brief information on various pharmaceutical products which includes entresto from Novartis, Daklinza from Bristol-Myers Squibb and Rexulti from Otsuka.

  • New Products.  // Drug Topics;5/12/2008, Vol. 152 Issue 6, p77 

    The article evaluates several drugs including Rotarix from GlaxoSmithKline, Orencia from Bristol-Myers Squibb Co., and OxyContin Tablets from Purdue Pharma Inc.

  • New management.  // Crain's New York Business;11/16/98, Vol. 14 Issue 46, p62 

    Focuses on changes in the management structure of Bristol-Myers Squibb Co.

  • Consumers targeted by Capoten promo.  // Drug Topics;9/5/94, Vol. 138 Issue 17, p8 

    Reports that Bristol-Myers Squibb has enlisted chain pharmacies in its first direct-to-consumer marketing campaign.

  • A hard one to swallow.  // Drug Topics;11/7/94, Vol. 138 Issue 21, p7 

    Reports that Bristol-Myers Squibb is withdrawing Questran tablets from the market after a patient choked on the large tablet.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics